Gene ID: 389125 (NCBI Gene)
Protein: 82-amino acid microprotein (UniProt: Q8IVN3)
Chromosomal Location: Chr3:52,825,287-52,827,777 (GRCh38/hg38)
Key Domains: Nuclear localization signal (residues 45-51)
Disease Associations:
| Condition | Association Type | Citations |
|---|---|---|
| Lacrimal system cancer | Gene expression link | |
| Fanconi anemia (complementation group B) | Pathway involvement | |
| Muscle fibrosis | ECM remodeling role |
| Tissue Type | Expression Level | Developmental Stage | Source |
|---|---|---|---|
| Skeletal muscle | High | Embryonic to adult | |
| Smooth muscle | Highest | Adult | |
| Cardiac muscle | Moderate | Postnatal | |
| Tendon | Moderate | Adult |
In situ hybridization reveals MUSTN1 expression in embryonic somites (E10.5-11.5), limb buds, and adult muscle nuclei . Single-cell RNA sequencing shows enrichment in vascular smooth muscle cells of muscle microvasculature .
Silencing MUSTN1 reduces myogenin (3-fold) and myosin heavy chain (4-fold) expression, impairing myotube formation . Heterozygous KO mice show altered fibronectin (FN1) and laminin (LAMA2) expression .
A 2024 study demonstrated MUSTN1 secretion kinetics:
Basal secretion: 0.8 ng/mL from human aortic SMCs
| Interactor | Function | Association Score |
|---|---|---|
| CSRP3 | Myogenesis cofactor | 0.436 |
| MYBPC1 | Myosin binding | 0.423 |
| TNMD | Angiogenesis regulation | 0.426 |
| DES | Intermediate filaments | N/A |
MUSTN1 co-expresses with MYOD1 (ρ=0.68) and MYOG (ρ=0.62) in differentiating myoblasts .
Target for muscle rehabilitation (post-atrophy recovery)
Mechanistic studies on MUSTN1’s dual nuclear/secreted roles
CRISPR screening for ECM-related interaction partners
Clinical trials assessing MUSTN1 levels in muscular dystrophies
Development of MUSTN1-based regenerative therapies
MUSTN1 (Musculoskeletal Temporarily Activated Novel Gene 1), also known as MUSTANG or musculoskeletal embryonic nuclear protein 1, is a small nuclear protein consisting of 82 amino acids. The gene has three exons with two introns between them and is exclusively expressed in vertebrate organisms . MUSTN1 shows high structural homology between mammals and is considered the only known pan-musculoskeletal cell marker, not belonging to any recognized class of proteins .
Methodological approach: To characterize MUSTN1 structurally, researchers should employ protein sequencing techniques, X-ray crystallography, or nuclear magnetic resonance (NMR) spectroscopy. Bioinformatic tools can be used for comparative analysis with homologous proteins in other species to identify conserved domains and potential functional motifs. Western blotting with specific antibodies can confirm protein expression in human tissue samples.
MUSTN1 expression is influenced by several transcription factors, including AP-1 family members such as c-Fos, Fra-2, and JunD . In animal models, the MyoD binding site has been shown to be crucial for MUSTN1 expression in skeletal muscles . MUSTN1 expression peaks at 3 months of age in mice, consistent with the expression pattern of MyoD .
Methodological approach: To study MUSTN1 regulation in human muscle development, researchers should utilize ChIP-seq (Chromatin Immunoprecipitation Sequencing) to identify transcription factor binding sites, and promoter-reporter assays to validate regulatory elements. Time-course studies with human muscle cell cultures during differentiation can track expression changes using RT-qPCR and immunocytochemistry.
Methodological approach: MUSTN1 expression in human samples can be analyzed using:
Transcriptomic analysis: RT-qPCR for mRNA quantification, RNAscope for localization in tissue sections
Proteomic analysis: Western blotting, immunohistochemistry, and immunofluorescence with validated antibodies
Single-cell approaches: Single-cell RNA sequencing to identify cell type-specific expression patterns
In situ hybridization: For spatial localization of MUSTN1 mRNA in tissue sections
Researchers should include appropriate housekeeping genes or proteins as controls and validate findings across multiple techniques.
MUSTN1 appears to be integral to myotube formation and muscle cell differentiation. Studies using RNA interference (RNAi) have shown that silencing MUSTN1 results in impaired myogenic differentiation and the downregulation of key fusion markers, leading to suppressed myotube formation . While much of this research has been conducted in animal models, the fundamental mechanisms are likely conserved in humans.
Methodological approach: To investigate MUSTN1's role in human myogenic differentiation, researchers should:
Use siRNA or CRISPR-Cas9 to knock down or knock out MUSTN1 in human primary myoblasts or immortalized cell lines
Analyze differentiation markers (e.g., myogenin, MyHC) by immunofluorescence and RT-qPCR
Quantify fusion index and myotube formation through morphometric analysis
Perform RNA sequencing to identify differentially expressed genes following MUSTN1 manipulation
Studies in animal models have shown that MUSTN1 is dynamically expressed in activated Pax7-positive skeletal muscle satellite cells during embryonic development and during phases of skeletal muscle repair and regeneration . When MUSTN1 was silenced using siRNA in chicken pectoralis muscle satellite cells, researchers observed decreased Pax7 expression, reduced satellite cell count, and decreased proliferation .
Methodological approach: To study MUSTN1's influence on human satellite cells:
Isolate primary human satellite cells using FACS based on cell surface markers
Manipulate MUSTN1 expression using viral vectors or nucleofection
Assess proliferation (EdU incorporation, Ki67 staining), self-renewal (Pax7 expression), and differentiation capacity
Perform lineage tracing experiments in 3D human muscle organoids
Analyze the satellite cell niche using co-culture systems with other cell types
Recent research has revealed intriguing connections between MUSTN1 and glucose metabolism. In a conditional knockout mouse model, ablation of MUSTN1 in skeletal muscle resulted in significantly lower glycemia in 2-month-old male mice during intraperitoneal glucose tolerance testing (IPGTT) . These metabolic changes were accompanied by increased expression of glucose transporters GLUT1 and GLUT10, as well as MUP-1, and decreased expression of OSTN .
Methodological approach: To investigate this relationship in human context:
Analyze MUSTN1 expression in muscle biopsies from individuals with different metabolic profiles
Use human muscle cell models with MUSTN1 knockdown to measure glucose uptake using labeled glucose
Perform metabolic flux analysis to assess glycolytic and oxidative metabolism
Examine expression of glucose transporters and metabolic enzymes following MUSTN1 manipulation
Analyze insulin signaling pathway components through phosphorylation studies
Interestingly, the metabolic phenotype observed in MUSTN1 knockout mice showed clear sex differences. The increased glucose tolerance and altered expression of metabolic genes were observed only in male mice, with female knockouts showing no significant differences compared to wild-type controls . Additionally, these effects appeared to be age-dependent, becoming statistically insignificant after 4 months of age .
Methodological approach: To investigate sex-specific differences:
Conduct comparative studies using male and female human muscle cells
Analyze the influence of sex hormones on MUSTN1 expression and function through hormone treatment studies
Examine potential hormonal response elements in the MUSTN1 promoter region
Perform population studies stratifying by sex to identify potential dimorphic effects
Investigate potential interactions with X-linked or Y-linked genes through bioinformatic approaches
The ablation of MUSTN1 in skeletal muscle significantly altered gene expression, with 213 genes upregulated and 93 downregulated, suggesting extensive interconnections with other genes within muscle tissue . Given MUSTN1's role in myogenic differentiation and satellite cell function, it may be implicated in various muscular disorders characterized by impaired regeneration or aberrant differentiation.
Methodological approach: To investigate MUSTN1's role in muscular disorders:
Analyze MUSTN1 expression in muscle biopsies from patients with different muscular dystrophies and myopathies
Develop disease-specific iPSC-derived muscle models with MUSTN1 manipulation
Use systems biology approaches to map MUSTN1-related pathways in disease contexts
Perform genetic association studies to identify MUSTN1 variants linked to muscle disorders
Test therapeutic approaches targeting MUSTN1 or its downstream effectors in disease models
Future research directions suggest exploring the relationship between insulin, mitochondria, and MUSTN1 to elucidate their complex interactions within the body's metabolic machinery . Understanding these interactions could provide insights into how MUSTN1 may influence glucose metabolism through effects on mitochondrial function and insulin signaling.
Methodological approach:
Assess mitochondrial respiration, biogenesis, and dynamics in human muscle cells with modified MUSTN1 expression
Analyze insulin signaling cascade components through phosphoproteomic approaches
Perform co-immunoprecipitation and proximity ligation assays to identify direct protein-protein interactions
Use subcellular fractionation to determine MUSTN1 localization in relation to mitochondria
Apply metabolomic profiling to identify metabolic pathways affected by MUSTN1 manipulation
Studies have shown that resistance training is linked to elevated MUSTN1 expression in human quadricep muscles following muscle lengthening and shortening . Additionally, in animal models, acute aerobic exercise and resistance training have been associated with increased MUSTN1 expression .
Methodological approach:
Conduct human exercise intervention studies with muscle biopsies before and after acute and chronic exercise
Apply single-cell approaches to identify cell type-specific responses to exercise
Develop ex vivo mechanical stretching models using human muscle tissue
Analyze epigenetic modifications of the MUSTN1 gene in response to different exercise modalities
Investigate potential exercise-responsive elements in the MUSTN1 promoter region
While MUSTN1 shows structural homology between mammalian species, there may be important functional differences to consider when translating findings to human contexts. Studies have used various models including mice, rats, chickens, zebrafish, and Xenopus, each with advantages for specific research questions .
Methodological approach:
Perform comparative genomics and proteomics of MUSTN1 across species
Validate findings across multiple model organisms before extrapolating to humans
Consider using humanized mouse models expressing human MUSTN1
Complement animal studies with human cell culture and organoid models
Apply bioinformatic approaches to predict functional conservation between species
The following table summarizes the advantages and limitations of different model systems for MUSTN1 research:
| Model System | Advantages | Limitations | Best Applications |
|---|---|---|---|
| Mouse models | Genetic manipulation tools; mammalian physiology | Some pathway differences from humans | In vivo metabolic studies; tissue-specific knockout |
| Human primary cells | Direct relevance to human biology | Limited lifespan; donor variability | Validation of mechanisms; personalized responses |
| Human iPSC-derived muscle | Patient-specific models; unlimited supply | Immature phenotype; technical complexity | Disease modeling; developmental studies |
| 3D organoids | Complex tissue architecture; long-term culture | Lack of systemic factors | Tissue-level responses; drug screening |
| Ex vivo human tissue | Preserved tissue architecture; human context | Limited availability; short viability | Physiological validation; contractile studies |
Methodological approach:
Design multiple siRNA sequences targeting different regions of MUSTN1 mRNA
Include appropriate controls (scrambled siRNA, untransfected cells)
Validate knockdown efficiency at both mRNA and protein levels
Consider potential off-target effects through transcriptome analysis
Use rescue experiments with siRNA-resistant MUSTN1 constructs to confirm specificity
Compare results from transient and stable knockdown approaches
Considering age-related changes in muscle function, investigating MUSTN1 in the context of aging could determine if it has a modulatory effect on muscle quality, particularly in eccentric and concentric muscle functions . Understanding this relationship might provide insights into age-related declines in muscle function.
Methodological approach:
Conduct age-comparison studies of MUSTN1 expression and function in human muscle biopsies
Develop in vitro aging models using prolonged culture or stress-induced premature senescence
Analyze MUSTN1-dependent pathways in young versus aged satellite cells
Investigate potential age-related post-translational modifications of MUSTN1
Explore intervention strategies targeting MUSTN1 pathways to mitigate age-related muscle decline
Future research exploring MUSTN1's interactions with epigenetic factors could provide insights into its regulation during development, disease, and aging. For example, examining whether MUSTN1 engages with epigenetic factors such as Prmt5, which controls adult skeletal muscle stem cell proliferation .
Methodological approach:
Perform ChIP-seq for histone modifications across the MUSTN1 locus in different cell states
Analyze DNA methylation patterns using bisulfite sequencing
Investigate chromatin accessibility through ATAC-seq
Examine interactions with chromatin modifiers using proximity ligation assays
Apply epigenetic editing techniques to modify specific regulatory elements
The MUSTN1 gene is located on chromosome 3 and is expressed in various tissues, particularly in the musculoskeletal system. The protein encoded by this gene is found in the nucleoplasm and is predicted to be involved in the positive regulation of chondrocyte differentiation and proliferation, as well as macromolecule metabolic processes .
MUSTN1 is essential for the proper development and function of skeletal muscle. It is involved in myoblast differentiation and fusion, which are critical processes for muscle fiber formation. Additionally, MUSTN1 modulates the composition of the skeletal muscle extracellular matrix, playing a role in maintaining muscle structure and function .
Studies have shown that MUSTN1 expression originates from Pax7-positive satellite cells in skeletal muscle and peaks around the third postnatal month. This expression is crucial for muscle fiber differentiation, fusion, growth, and regeneration. MUSTN1 responds dynamically to injury and exercise, indicating its importance in muscle repair and adaptation .
MUSTN1 has been linked to various musculoskeletal conditions. For instance, its expression is potentially associated with muscle-wasting conditions such as muscular dystrophies. Ablation of MUSTN1 in skeletal muscle affects several physiological aspects, including glucose metabolism, grip strength, gait, peak contractile strength, and myofiber composition .
Diseases associated with MUSTN1 include encephalomalacia and autosomal recessive deafness 55. An important paralog of this gene is STIMATE, which also plays a role in musculoskeletal development .